Adducts and N-oxides: Understanding Lipid Nanoparticles (LNPs) for Better mRNA-Based
Webinar Date/Time: Wed, May 3, 2023 11:00 AM EDT
The development of genetic medications using lipid nanoparticles (LNPs) requires rethinking analytical technology. Learn how to gain valuable insights into your LNP quality in a new and streamlined manner.
Register Free: https://globalmeet.webcasts.com/starthere.jsp?ei=1606499&tp_key=d13abe9fc0
Event Overview:
Lipid nanoparticles (LNPs)—composed of helper lipids, PEGylated lipids and ionizable lipids—are widely used vehicles for oligonucleotide-based therapeutics and vaccines. However, mRNA LNPs are susceptible to inactivation of their payload by N-oxide-based impurities. Distinguishing harmful N-oxides from other oxidation products can be an analytical challenge for most existing technology, especially for ionizable lipids, as they come with various structures consisting of several potential oxidation sites. To complicate matters, harmful impurities can be present at very low abundance. This webinar explains how to address challenges related to N-oxide-based impurities during LNP-based development.
Key Learning Objectives:
- Discover why process-related lipid impurities are a concern in LNP therapeutics and vaccines
- Explore how to achieve detailed characterization of ionizable lipids by using liquid chromatography with mass spectrometry (LC-MS) and leveraging more descriptive fragmentation
- Learn how to elucidate structures of ionizable lipid impurities, allowing differentiation of oxidative species and positioning of double bonds and saturations at low levels
- Hear about streamlining complex data interpretation of ionizable lipid fragmentation with dedicated novel software for MS/MS interpretation
Featured Speaker:
Dr. Adam Crowe
Manager Analytical Development
Precision NanoSystems ULC
Adam Crowe manages a multi-discipline team at Precision NanoSystems ULC, tasked with developing novel analytical assays related to lipid nanoparticles (LNPs) and nanomaterials for drug delivery. During his tenure, Adam has garnered broad expertise over the 50+ unique LNP compositions manufactured at PNI in analyzing particle payloads, excipients (such as lipids), physiochemical characteristics, and in vitro potency. Notably, Adam and his team have increasingly leveraged cutting-edge technologies, such as LC-MS approaches, to tackle the complexities of LNP characterization. Additionally, Adam is the technical lead for ASTM’s guide document on analytical methodologies for RNA LNPs, a comprehensive document drafted by leaders in industry, academia, and regulatory bodies outlining best analytical practices for the LNP field.
Register Free: https://globalmeet.webcasts.com/starthere.jsp?ei=1606499&tp_key=d13abe9fc0
Using Chromatography to Study Microplastics in Food: An Interview with Jose Bernal
December 16th 2024LCGC International sat down with Jose Bernal to discuss his latest research in using pyrolysis gas chromatography–mass spectrometry (Py-GC–MS) and other chromatographic techniques in studying microplastics in food analysis.
Next Generation Peak Fitting for Separations
December 11th 2024Separation scientists frequently encounter critical pairs that are difficult to separate in a complex mixture. To save time and expensive solvents, an effective alternative to conventional screening protocols or mathematical peak width reduction is called iterative curve fitting.
Investigating the Influence of Packaging on the Volatile Profile of Oats
December 10th 2024In the testing of six different oat brands, headspace sorptive extraction and comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry (GC×GC–TOF-MS) reveal how various packaging types can affect and alter the oats’ volatile profile, underscoring the potential impact of packaging on food quality.
